__NUXT_JSONP__("/drugs/Emepepimut-S", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"221214-84-2",chebiId:b,chemicalFormula:b,definition:"A liposome-encapsulated peptide vaccine consisting of a synthetic peptide derived from the mucin 1 (MUC-1) antigen with potential antineoplastic activity. Upon vaccination, MUC-1 peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against MUC-1-expressing tumor cells, resulting in growth inhibition. MUC-1 antigen is a high-molecular-weight transmembrane glycoprotein that is overexpressed on the cell surfaces of many epithelial tumor cells as well as on the cell surfaces of some B-cell lymphoma cells and multiple myeloma cells.",fdaUniiCode:"Q7Y026G2CX",identifier:"C2195",preferredName:a,semanticType:"Immunologic Factor",subclassOf:["C1663","C1752"],synonyms:["BLP 25","BLP-25","BLP-25 Liposomal Vaccine","BLP25","BLP25 Liposome Vaccine","BP1-7-KLH","EMD 531444",a,"Glycine, L-seryl-L-threonyl-L-alanyl-L-prolyl-L-prolyl-L-alanyl-L-histidylglycyl-L-valyl-L-threonyl-L-seryl-L-alanyl-L-prolyl-L-alpha-aspartyl-L-threonyl-L-arginyl-L-prolyl-L-alanyl-L-prolylglycyl-L-seryl-L-threonyl-L-alanyl-L-prolyl-L-prolyl-N6-(1-oxohexadecyl)-L-lysyl-","L-BLP25","Stimuvax","TECEMOTIDE","Tecemotide"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FEmepepimut-S",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Emepepimut-S","","2021-10-30T13:37:19.353Z")));